Pathology
 |
|
21 august 2019 16:00:58 |
| Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia (Leukemia) |
|
Tweet |
| 198 viewsCategory: Pathology |
 Leukemia evolving from paroxysmal nocturnal hemoglobinuria (Leukemia)Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing (Leukemia) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
